Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
08:03am, Tuesday, 19'th Nov 2024
CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
10:51am, Friday, 15'th Nov 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
08:03am, Wednesday, 13'th Nov 2024
CORAL GABLES, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
08:51am, Monday, 11'th Nov 2024
Madrigal, Corcept, Catalyst Larimar and Theravance have been highlighted in this Industry Outlook article.
5 Small Drug Stocks to Buy as Trump Gets Re-Elected
08:21am, Friday, 08'th Nov 2024
Innovation is at its peak for the Zacks Medical-Drugs industry. MDGL, CORT, CPRX, LRMR and TBPH may prove to be good additions to one's portfolio.
CPRX Q3 Earnings & Revenues Beat Estimates, '24 View Raised, Stock Up
11:30am, Thursday, 07'th Nov 2024
Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales. Management raises sales guidance.
Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript
10:34am, Thursday, 07'th Nov 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Richard Daly - President and Chief Executive Officer Michael Kalb - Chie
Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
10:20am, Thursday, 07'th Nov 2024
Catalyst (CPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say
07:00pm, Wednesday, 06'th Nov 2024
The headline numbers for Catalyst (CPRX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street est
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
06:26pm, Wednesday, 06'th Nov 2024
Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to loss of $0.24 per share a year ago.
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
04:12pm, Wednesday, 06'th Nov 2024
Reports Q3 2024 Total Revenues of $ 128.7 Million, Representing a 25.3 % YoY Increase
CPRX vs. STVN: Which Stock Is the Better Value Option?
12:45pm, Wednesday, 06'th Nov 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two companies is the best option for tho
Pick These 4 Solid Net Profit Margin Stocks to Boost Portfolio Return
10:05am, Monday, 28'th Oct 2024
Pick these four top-ranked stocks, VRT, LMB, ATAT and CPRX, with solid net profit margins to enhance your portfolio returns.
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024
08:03am, Tuesday, 22'nd Oct 2024
The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET
CPRX or STVN: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 21'st Oct 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks presents investor
